-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 24, the National Medical Security Administration made an official reply to the proposal No.
7308 of the Fifth Session of the 13th National People's Congress - "Proposal on Implementing Pharmacy Service Fees as Soon as Possible to Give Full Play to the Power of Pharmacists"
.
The reply stated that in 2021, the General Office of the State Council will issue the "Notice of the "14th Five-Year Plan" National Medical Security Plan", which clearly proposes to "explore and improve the price of pharmaceutical medical services"
.
At present, the National Medical Insurance Administration is carrying out the preparation of the national medical service price specification based on the principle of service output-oriented, medical human resource consumption as the basis, and separation of technical labor and material consumption.
On the basis of clarifying the boundaries of pharmaceutical medical services, For pharmaceutical service matters with clear patient needs, specific service content and objects, and clear technical route, research and improve price items to support the healthy and orderly development of pharmaceutical services
.
At present, Fujian Province has been instructed to take the lead in launching a pilot project on the price of pharmaceutical services
.
At present, all provinces across the country have established a dynamic adjustment mechanism for medical service prices, and will conduct price adjustment assessments on a regular basis.
Those that meet the start-up conditions will adjust prices within the range of total control
.
The National Medical Insurance Administration will guide all localities to consider the cost and value of pharmaceutical services in the price of medical services, support the development of pharmaceutical services, and encourage pharmacists to play an active role in promoting rational drug use and reducing waste of resources
.
Beginning in 2019, the state organized the centralized procurement of multiple batches of medicines with volume , and implemented the policy of retaining the balance of special medical insurance funds .
The remaining funds are used as an incentive for medical institutions to actively participate in the reform of centralized procurement and actively use the selected drugs to save drug costs, and it is also a reflection of the value of pharmaceutical personnel in promoting rational drug use .
According to the policy requirements, public medical institutions should rationally use the remaining funds, improve the distribution and incentive mechanism, and fully transmit the reform dividends to pharmacy personnel.
.
In the next step, the National Medical Insurance Administration will continue to actively implement the policy of retaining the balance of medical insurance funds for centralized procurement of drugs, study and issue guidelines for the establishment of pharmaceutical medical service price projects as soon as possible, coordinate the promotion of the pilot reform of medical service prices, and summarize and promote local practices that reflect the value of pharmaceutical services
.
Guide local governments to explore the inclusion of eligible pharmaceutical medical service price items into the scope of medical insurance payment, so as to better meet the needs of insured patients for pharmaceutical medical services
.
At the same time, it will also actively cooperate with the National Health Commission and other relevant departments to do a good job in the management of pharmaceutical affairs in medical institutions.
In the reform and management, the cost and value of pharmaceutical services will be taken into consideration to support the development of pharmaceutical services
.
On August 24, the National Medical Security Administration made an official reply to the proposal No.